137 related articles for article (PubMed ID: 26324679)
21. The major prognostic factors of thymomas: about a Tunisian study of 100 cases.
Mlika M; Boudaya MS; Laabidi S; Zaimi Y; Smadhi H; Marghli A; El Mezni F; Kilani T
Pathologica; 2015 Mar; 107(1):9-13. PubMed ID: 26591625
[TBL] [Abstract][Full Text] [Related]
22. Does the World Health Organization histological classification predict outcomes after thymomectomy? Results of a multicentre study on 750 patients.
Guerrera F; Rendina EA; Venuta F; Margaritora S; Ciccone AM; Novellis P; Novero D; Anile M; Bora G; Rena O; Casadio C; Mussi A; Evangelista A; Ruffini E; Lucchi M; Filosso PL
Eur J Cardiothorac Surg; 2015 Jul; 48(1):48-54. PubMed ID: 25246487
[TBL] [Abstract][Full Text] [Related]
23. Extended surgical resections of advanced thymoma Masaoka stages III and IVa facilitate outcome.
Ried M; Potzger T; Sziklavari Z; Diez C; Neu R; Schalke B; Hofmann HS
Thorac Cardiovasc Surg; 2014 Mar; 62(2):161-8. PubMed ID: 23775415
[TBL] [Abstract][Full Text] [Related]
24. Thymoma--the usefulness of some prognostic factors for diagnosis and surgical treatment.
Gawrychowski J; Rokicki M; Gabriel A; Lackowska B; Czyzewski D
Eur J Surg Oncol; 2000 Apr; 26(3):203-8. PubMed ID: 10753530
[TBL] [Abstract][Full Text] [Related]
25. Thymomas and thymic carcinomas: prognostic factors and multimodal management.
Moser B; Scharitzer M; Hacker S; Ankersmit J; Matilla JR; Lang G; Aigner C; Taghavi S; Klepetko W
Thorac Cardiovasc Surg; 2014 Mar; 62(2):153-60. PubMed ID: 23225512
[TBL] [Abstract][Full Text] [Related]
26. World Health Organization classification of thymomas provides significant prognostic information for selected stage III patients: evidence from an international thymoma study group.
Marchevsky AM; Gupta R; Casadio C; Hiroshima K; Jambhekar NA; Kim DJ; Nakatani Y; Okumura M; Rena O; Yoshida S
Hum Pathol; 2010 Oct; 41(10):1413-21. PubMed ID: 20573368
[TBL] [Abstract][Full Text] [Related]
27. Surgical resection of thymoma still represents the first choice of treatment.
Ried M; Guth H; Potzger T; Diez C; Neu R; Schalke B; Hofmann HS
Thorac Cardiovasc Surg; 2012 Mar; 60(2):145-9. PubMed ID: 21692020
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic and Prognostic Implications of Programmed Death Ligand 1 Expression in Thymoma.
Yokoyama S; Miyoshi H; Nishi T; Hashiguchi T; Mitsuoka M; Takamori S; Akagi Y; Kakuma T; Ohshima K
Ann Thorac Surg; 2016 Apr; 101(4):1361-9. PubMed ID: 26794891
[TBL] [Abstract][Full Text] [Related]
29. Conditional survival of malignant thymoma using national population-based surveillance, epidemiology, and end results (SEER) registry (1973-2011).
Kim E; Thomas CR
J Thorac Oncol; 2015 Apr; 10(4):701-7. PubMed ID: 25590603
[TBL] [Abstract][Full Text] [Related]
30. [Correlations of novel histological classification of 82 thymoma patients to their clinical characteristics and prognosis].
Su XD; Rong TH; Long H; He JH; Zhang LJ; Zhang X; Zhao JM
Ai Zheng; 2005 Nov; 24(11):1363-6. PubMed ID: 16552964
[TBL] [Abstract][Full Text] [Related]
31. Thymoma patients with pleural dissemination: nationwide retrospective study of 136 cases in Japan.
Okuda K; Yano M; Yoshino I; Okumura M; Higashiyama M; Suzuki K; Tsuchida M; Usuda J; Tateyama H
Ann Thorac Surg; 2014 May; 97(5):1743-8. PubMed ID: 24657034
[TBL] [Abstract][Full Text] [Related]
32. Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma?
Rena O; Papalia E; Oliaro A; Ruffini E; Filosso P; Novero D; Maggi G; Casadio C
Eur J Cardiothorac Surg; 2007 Jan; 31(1):109-13. PubMed ID: 17110124
[TBL] [Abstract][Full Text] [Related]
33. Impact of the TNM staging system for thymoma.
Smith A; Cavalli C; Harling L; Harrison-Phipps K; Routledge T; Pilling J; King J; Bille A; Nonaka D
Mediastinum; 2021; 5():32. PubMed ID: 35118337
[TBL] [Abstract][Full Text] [Related]
34. Long-term survival and prognostic factors in thymic epithelial tumours.
Rea F; Marulli G; Girardi R; Bortolotti L; Favaretto A; Galligioni A; Sartori F
Eur J Cardiothorac Surg; 2004 Aug; 26(2):412-8. PubMed ID: 15296907
[TBL] [Abstract][Full Text] [Related]
35. Clinical evaluation of a new tumour-node-metastasis staging system for thymic malignancies proposed by the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and the International Thymic Malignancy Interest Group.
Fukui T; Fukumoto K; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Hirakawa A; Tateyama H; Yokoi K
Eur J Cardiothorac Surg; 2016 Feb; 49(2):574-9. PubMed ID: 26547095
[TBL] [Abstract][Full Text] [Related]
36. Treatment Outcome and Prognostic Factors of Malignant Thymoma - A Single Institution Experience.
Alothaimeen HS; Memon MA
Asian Pac J Cancer Prev; 2020 Mar; 21(3):653-661. PubMed ID: 32212790
[TBL] [Abstract][Full Text] [Related]
37. Outcome of multimodality treatment for 188 cases of type B3 thymoma.
Gao L; Wang C; Fang W; Zhang J; Lv C; Fu S
J Thorac Oncol; 2013 Oct; 8(10):1329-34. PubMed ID: 24457243
[TBL] [Abstract][Full Text] [Related]
38. Outcome in excised thymomas: role of prognostic factors and impact of additional malignancies on survival.
Granato F; Blackhall V; Alessandra R; Spina D; Luca V; Piero P; Mohiyaddin S; Asif M; Kirk AJ; Giuseppe G
Scott Med J; 2014 Feb; 59(1):22-9. PubMed ID: 24463694
[TBL] [Abstract][Full Text] [Related]
39. Assessment of multimodality therapy for thymoma.
Chen J; Wang P
Chin Med J (Engl); 2010 May; 123(10):1295-8. PubMed ID: 20529584
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological features of thymic carcinomas and the impact of histopathological agreement on prognostical studies.
Roden AC; Yi ES; Cassivi SD; Jenkins SM; Garces YI; Aubry MC
Eur J Cardiothorac Surg; 2013 Jun; 43(6):1131-9. PubMed ID: 23086701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
